- Home
- NMR vs ICLR Comparison
NMR vs ICLR Comparison
Compare NMR & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMR
- ICLR
- Stock Information
- Founded
- NMR 1925
- ICLR 1990
- Country
- NMR Japan
- ICLR Ireland
- Employees
- NMR N/A
- ICLR N/A
- Industry
- NMR Investment Bankers/Brokers/Service
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- NMR Finance
- ICLR Health Care
- Exchange
- NMR Nasdaq
- ICLR Nasdaq
- Market Cap
- NMR 16.4B
- ICLR 17.2B
- IPO Year
- NMR 1961
- ICLR 1998
- Fundamental
- Price
- NMR $5.99
- ICLR $198.11
- Analyst Decision
- NMR Hold
- ICLR Strong Buy
- Analyst Count
- NMR 1
- ICLR 12
- Target Price
- NMR N/A
- ICLR $284.82
- AVG Volume (30 Days)
- NMR 483.9K
- ICLR 873.1K
- Earning Date
- NMR 02-05-2025
- ICLR 02-19-2025
- Dividend Yield
- NMR N/A
- ICLR N/A
- EPS Growth
- NMR 108.50
- ICLR 44.49
- EPS
- NMR 0.62
- ICLR 8.99
- Revenue
- NMR $12,446,225,835.00
- ICLR $8,306,823,000.00
- Revenue This Year
- NMR $43.86
- ICLR $3.95
- Revenue Next Year
- NMR N/A
- ICLR $2.84
- P/E Ratio
- NMR $9.19
- ICLR $22.53
- Revenue Growth
- NMR 24.23
- ICLR 3.63
- 52 Week Low
- NMR $4.66
- ICLR $183.38
- 52 Week High
- NMR $6.62
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- NMR 60.14
- ICLR 35.86
- Support Level
- NMR $5.52
- ICLR $196.50
- Resistance Level
- NMR $5.89
- ICLR $228.29
- Average True Range (ATR)
- NMR 0.09
- ICLR 6.57
- MACD
- NMR 0.02
- ICLR -1.36
- Stochastic Oscillator
- NMR 100.00
- ICLR 5.06
About NMR Nomura Holdings Inc ADR
Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions worldwide including Japan, the U.S., the U.K., Singapore, and the Hong Kong Special Administrative Region ("Hong Kong") through its subsidiaries. The company's clients include individuals, corporations, financial institutions, governments, and governmental agencies. The company's business consists of Wealth Management*, Investment Management, and Wholesale. The company generates the majority of its revenue from the wholesale segment. The Wholesale Division consists of two businesses, Global Markets, which is mainly engaged in the trading, sales, and structuring of financial products, and Investment Banking which is engaged in advisory, financing, and solutions businesses.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.